NCT06084884
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT06084884
Title A Phase I/II Study to Evaluate AZD5851 in GPC3+ Advanced/Recurrent Hepatocellular Carcinoma (ATHENA)
Acronym ATHENA
Recruitment Active, not recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors AstraZeneca
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA

Facility Status City State Zip Country Details
Research Site Phoenix Arizona 85054 United States Details
Research Site Duarte California 91010 United States Details
Research Site Orange California 92868 United States Details
Research Site San Francisco California 94143 United States Details
Research Site Washington D.C. District of Columbia 20007 United States Details
Research Site Jacksonville Florida 32224 United States Details
Research Site Atlanta Georgia 30322 United States Details
Research Site Westwood Kansas 66205 United States Details
Research Site Rochester Minnesota 55905 United States Details
Research Site Hackensack New Jersey 07601 United States Details
Research Site New York New York 10065 United States Details
Research Site Columbus Ohio 43210 United States Details
Research Site Portland Oregon 97239 United States Details
Research Site Philadelphia Pennsylvania 19104 United States Details
Research Site Pittsburgh Pennsylvania 15237 United States Details
Research Site Kashiwa 227-8577 Japan Details
Research Site Osakasayama-shi 589-8511 Japan Details
Research Site Seoul 03080 South Korea Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field